Eledon Pharmaceuticals Inc. (ELDN) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Eledon Pharmaceuticals In...

NASDAQ: ELDN · Real-Time Price · USD
2.84
0.08 (2.90%)
At close: Oct 03, 2025, 3:59 PM
2.86
0.70%
After-hours: Oct 03, 2025, 07:31 PM EDT

Eledon Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
20.55M 4.61M 56.41M 84.83M
Short-Term Investments
119.63M 46.49M n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
363K 186K 150K 400K
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
729K 90K 28K 34K
Total Current Assets
143.73M 56.13M 59.52M 88.35M
Property-Plant & Equipment
926K 365K 739K 768K
Goodwill & Intangibles
32.39M 32.39M 32.39M 81.03M
Total Long-Term Assets
33.67M 32.94M 33.27M 82.2M
Total Assets
177.41M 89.07M 92.79M 170.55M
Account Payables
5.83M 967K 2.2M 1.81M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
314K n/a 363K 369K
Other Current Liabilities
1.29M 2M 1.64M 1.15M
Total Current Liabilities
11.58M 3.9M 6.47M 4.4M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
44.87M 76.21M n/a n/a
Total Long-Term Liabilities
47.69M 77.96M 2.13M 2.15M
Total Liabilities
59.27M 81.86M 8.61M 6.55M
Total Debt
954K 383K 746K 769K
Book Value
118.14M 7.21M 84.18M 164M
Book Value Per Share
2.43 0.29 5.89 11.07
Common Stock
60K 24K 14K 14K
Retained Earnings
-355.59M -319.4M -202.87M -114.9M
Comprehensive Income
26K n/a 0.00 n/a
Shareholders Equity
118.14M 7.21M 84.18M 164M
Total Investments
119.63M 46.49M n/a n/a